Cartilage Tissue Stiffness via TMAO and Urea Culture Medium

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

Current tissue culture media do not effectively promote the development of cartilage tissue with enhanced mechanical properties, such as increased stiffness and collagen content, which is crucial for regenerative applications.

Innovation Solution

Incorporating trimethylamine N-oxide (TMAO) and urea into a chondrogenic tissue culture medium, along with chondroitinase (cABC) for controlled enzymatic treatment, to create a culture environment that promotes the production of stiffer cartilage tissue with improved mechanical properties.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Strength

If conventional tissue culture media are used, then cartilage tissue can be produced, but the mechanical properties (stiffness and collagen content) are insufficient

Engineering Contradiction:

Improvemechanical properties of cartilage tissueVSAvoideffectiveness of tissue culture media

Core Design Contradiction:

StrengthVSReliability

Solution Approach 1:

The patent changes the chemical composition parameters of the culture medium by adding TMAO (trimethylamine N-oxide) and urea, which are naturally occurring osmolytes. These parameter changes in the medium composition directly improve the mechanical properties of produced cartilage tissue, including increased stiffness and collagen content, while maintaining the reliability of the culture system.

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The invention creates a composite culture medium that combines conventional nutrients with TMAO and urea. This composite medium leverages the synergistic effects of multiple components to enhance cartilage tissue mechanical properties beyond what conventional media can achieve alone.

Inventive Principle:

Principle #40Composite materials

2Quantity of substance

If chondroitinase treatment is applied, then collagen content increases, but the process complexity increases

Engineering Contradiction:

Improvecollagen contentVSAvoidprocess complexity

Core Design Contradiction:

Quantity of substanceVSDevice complexity

Solution Approach 1:

The patent applies chondroitinase treatment at a specific stage during the culture process to preliminarily modify the extracellular matrix before final tissue maturation. This timing strategy allows the enzyme to selectively degrade chondroitin sulfate while preserving collagen synthesis, increasing collagen content without requiring complex additional processing steps.

Inventive Principle:

Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The use of TMAO and urea in the culture medium, combined with cABC treatment, results in cartilage tissue with significantly increased stiffness and collagen content, effectively addressing the limitations of existing media in producing tissue with enhanced mechanical properties.

Implementation Method 1

TMAO is thought to counteract the effects of urea by stabilizing protein folding in shark tissue

Methodology Applied

Scientific EffectProtein folding stabilization:

Implementation Method 2

digesting cultured chondrogenic progenitor cells with chondroitinase

Methodology Applied

Scientific EffectEnzymatic degradation: Enzyme

Data Source

PatentUS9321993B2Tissue culture method for producing cartilage using trimethylamine N-oxide and chondroitinase

Publication Date: 2016.04.26 THE TRUSTEES OF COLUMBIA UNIV IN THE CITY OF NEW YORK

AI summary

The present disclosure provides cell culture medium comprising trimethylamine N-oxide (TMAO). Progenitor cells cultured with such medium can form connective tissue with enhanced mechanical properties. Also provided are methods of forming connective tissue and methods of treatment for connective tissue defects.